Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hao‑Lun Luo"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Urothelial carcinoma (UC) is a common cancer characterized by high morbidity and mortality rates. Despite advancements in treatment, challenges such as recurrence and low response rates persist. Antibody-drug conjugates (ADCs) have emerged as a promi
Externí odkaz:
https://doaj.org/article/252b1a6b46b5414f956e2d41ef98ad90
Autor:
Ying-Che Huang, Hung-Jen Wang, Min-Tse Sung, Yao-Chi Chuang, Yen-Ta Chen, Yuan-Tso Cheng, Chih-Hsiung Kang, Hui-Ying Liu, Yin-Lun Chang, Po-Hui Chiang, Hao-Lun Luo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo evaluate the prognostic impact of the lowest level of tumor location for upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU).Materials and methodsData were collected from patients with UTUC treated with RNU
Externí odkaz:
https://doaj.org/article/b9fb17d9110b4606b5e6e98cce8bc747
Autor:
Jei-Ming Peng, Ching-Feng Chiu, Jai-Hong Cheng, Hui-Ying Liu, Yin-Lun Chang, Jia-Wun Luo, Yu-Ting Weng, Hao-Lun Luo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cancer immunotherapy uses the immune system to achieve therapeutic effects; however, its effect is still limited. Therefore, in addition to immune checkpoint-based treatment, the development of other strategies that can inhibit cancer cells from resi
Externí odkaz:
https://doaj.org/article/3ce76e1432b84f32a4780b3eb4f89839
Autor:
Chun-Chieh Huang, I-Chieh Chuang, Yu-Li Su, Hao-Lun Luo, Ya-Chun Chang, Jo-Ying Chen, Chang-Chun Hsiao, Eng-Yen Huang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionTo investigate the role of tumor galectin-1 and galectin-3 in patients with lung adenocarcinoma after definitive radiation therapy.MethodsA total of 41 patients with localized lung adenocarcinoma undergoing thoracic radiation therapy with
Externí odkaz:
https://doaj.org/article/76ab405d8f2c4a86ae8192045fe53f15
Autor:
Hong-Yue Lai, Li-Ching Wu, Po-Hsin Kong, Hsin-Hwa Tsai, Yen-Ta Chen, Yuan-Tso Cheng, Hao-Lun Luo, Chien-Feng Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundThe unusual high dialysis prevalence and upper urinary tract urothelial carcinoma (UTUC) incidence in Taiwan may attribute to aristolochic acid (AA), which is nephrotoxic and carcinogenic, exposure. AA can cause a unique mutagenic pattern s
Externí odkaz:
https://doaj.org/article/288b7b5c8b244bc1930bb852eea6c692
Autor:
Ming-Chun Kuo, Po-Jung Su, Chun-Chieh Huang, Hao-Lun Luo, Tai-Jan Chiu, Shau-Hsuan Li, Chia-Che Wu, Ting-Ting Liu, Yuan-Tso Cheng, Chih-Hsiung Kang, Yu-Li Su
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundImmune checkpoint inhibitors (ICIs) are used widely for treating metastatic urothelial carcinoma (mUC). In practical settings, evidence is lacking on the efficacy of ICIs in some difficult-to-treat patients, such as those with end-stage ren
Externí odkaz:
https://doaj.org/article/7362a60ed75a425ca16c8c2ae2a52175
Autor:
Chun-Chieh Huang, Yu-Li Su, Hao-Lun Luo, Yen-Ta Chen, Terence T. Sio, Hsuan-Chih Hsu, Chia-Hsuan Lai
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Our hospital is a tertiary medical center located in southern Taiwan, which is an endemic area for upper tract urothelial carcinoma (UTUC) cases. Using a large registry-based surgical database, we examined our cohort of patients with UT
Externí odkaz:
https://doaj.org/article/e4618fab41db46fd8cef78cc0c666d58
Autor:
Shun-Chen Huang, Hung-Jen Wang, Yen-Ta Chen, Yao-Chi Chuang, Chun-Chieh Huang, Hui-Ying Liu, Chih Hsiung Kang, Yuan-Tso Cheng, Hao Lun Luo, Wei Ching Lee, Yu-Li Su, Po Hui Chiang, Yin-Lun Chang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
PurposeTo assess the association of tumor architecture with cancer recurrence, metastasis, and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) in Taiwan.Mate
Autor:
Tzu Shuang Chen, Yen Ta Chen, Hung Jen Wang, Po Hui Chiang, Wen Chou Yang, Wei Ching Lee, Yao Chi Chuang, Yuan Tso Cheng, Chih Hsiung Kang, Wei Chia Lee, Chien Hsu Chen, Yuan Chi Shen, Yi Yang Liu, Hui Ying Liu, Yin Lun Chang, Yu Li Su, Chun Chieh Huang, Hao Lun Luo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundWe aimed to evaluate the impact of tumor location on cancer outcomes in patients with pT3N0M0 upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU) with bladder cuff excision.Materials and MethodsWe retrospec
Externí odkaz:
https://doaj.org/article/6d872255678342ac849d33dfed0bf4af
Autor:
Cheng Chih Wu, Po Yen Chen, Shih Wei Wang, Meng Hsuan Tsai, Yu Chin Lily Wang, Ching Ling Tai, Hao Lun Luo, Hung-Jen Wang, Chung Yu Chen
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Androgen deprivation therapy (ADT) suppresses the production of androgen, and ADT is broadly used for intermediate or higher risk disease including advanced and metastatic cancer. ADT is associated with numerous adverse effects derived fr
Externí odkaz:
https://doaj.org/article/328e9dc384a04dfb91a357d07e053d7f